SCHEMBL3977087

SCHEMBL3977087

NC(=S)Nc1cccc(OCCCOc2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 2/20 0.54
F2 P00734 1/20 0.54
PLG P00747 1/20 0.54
PRSS2 P07478 1/20 0.54
C1S P09871 1/20 0.54
PRSS3 P35030 1/20 0.54
ALDH1A1 P00352 4/20 0.53
TP53 P04637 1/20 0.53
TYR P14679 1/20 0.53
TSHR P16473 1/20 0.53
TAS2R38 P59533 1/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 2/20 0.51
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 2/20 0.49
MEN1 O00255 2/20 0.48
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973757 0.97 ALDH1A1 (0.53) PRSS1F2PLGPRSS2C1S
SCHEMBL3978614 0.95 ALDH1A1 (0.51) PRSS1F2PLGPRSS2C1S
SCHEMBL3977061 0.95 ALDH1A1 (0.51) PRSS1F2PLGPRSS2C1S
SCHEMBL3974860 0.95 ALDH1A1 (0.51) PRSS1F2PLGPRSS2C1S
SCHEMBL3975168 0.93 F2 (0.48) PRSS1F2PLGPRSS2C1S
SCHEMBL3975905 0.90 FABP1 (0.48) PRSS1F2PLGPRSS2C1S
SCHEMBL3984003 0.90 ALDH1A1 (0.50) PRSS1F2PLGPRSS2C1S
SCHEMBL3976349 0.89 FABP1 (0.50) PRSS1F2PLGPRSS2C1S
SCHEMBL3978599 0.89 FABP1 (0.50) PRSS1F2PLGPRSS2C1S
SCHEMBL3978333 0.89 FABP1 (0.50) PRSS1F2PLGPRSS2C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101522184-A Thiourea compounds NAT HEALTH RESEARCH INSTITUTES (CN) 2009-09-02 CN disclosed
EP-2056810-A2 THIOUREA COMPOUNDS National Health Research Institutes (TW) 2009-05-13 EP disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed
WO-2008022204-A2 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 PRSS1 3925/4885F2 2960/4885PLG 4878/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 PRSS1 3857/4885F2 3049/4885PLG 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.